Certified by Founder Lodge
Gimv
Belgium - Antwerp
INVESTOR
1 Disclosed Funding Rounds $105,000,000
4 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Guiding companies - Benefitting society
Gimv is a European investment company with more than 40 years' experience in private equity. Listed on Euronext Brussels, we have 2 billion EUR AUM
| Company | Date | Round | Raised |
|---|---|---|---|
 Mediar Therapeutics |
March, 15 ,2023 | Unknown | $105,000,000 |
 Complement Therapeutics |
April, 18 ,2023 | Series A | $78,929,000 |
 Kinaset Therapeutics |
January, 13 ,2026 | Series B | $103,000,000 |
 EXCIVA GmbH |
January, 20 ,2026 | Series B | $59,817,135 |
Founderpath
Truework
Finix
Farther
TeamApt Inc.
Poetiq | $45,800,000 | (Feb 3, 2026)
1Buy.AI | $3,900,000 | (Feb 3, 2026)
Principle | $2,000,000 | (Feb 3, 2026)
Prenosis | $20,000,000 | (Feb 3, 2026)
PranaX | $17,000,000 | (Feb 3, 2026)
